Navigation Links
Thin tough skin, slow-growing gills protect larval Antarctic fish

Very thin but hardy, unblemished skin and slow developing gills appear to be keys to survival for newly hatched Antarctic notothenioids, a group of fish whose adults thrive in icy waters because of antifreeze proteins (AFPs) in their blood.

Such adaptations are important, researchers at the University of Illinois atUrbana-Champaign say, because the larval fish of at least two species of notothenioids that inhabit the Ross Sea at McMurdo Sound and Terra Nova Bay surprisingly lack sufficient antifreeze to protect them through their first three months of life.

The unexpected discovery, reported online by the Journal of Experimental Biology ahead of regular publication, counters the assumption that these vital proteins must be present from the time of hatching -- a view held by scientists since fish AFPs were found in the 1960s.

Internal fluids such as blood in many notothenioids are about half as salty as seawater. While seawater reaches its freezing point at -1.91 degrees Celsius, fish fluids will freeze at about -1 degree Celsius. The water where these species dwell rarely rises above the freezing point and is regularly filled with ice crystals.

"The way that we've understood how adult polar fishes survive has been based on their use of these antifreeze proteins to lower the freezing point of their internal fluids," said lead author Paul A. Cziko, a research specialist in the department of animal biology. "We finally got a chance to look at the larval fish, and it seems that they don't always have to have antifreeze proteins to survive."

Cziko, who earned bachelor's degrees in honors biology and biochemistry in 2004 from Illinois, studied in Antarctica as an undergraduate with animal biology professors Chi-Hing (Christina) Cheng and Arthur L. DeVries, who discovered AFPs in notothenioids.

The research team, which also included Clive W. Evans of the University of Auckland in New Zealand, studied three notothenioid species
'"/>

Source:University of Illinois at Urbana-Champaign


Page: 1 2 3

Related biology news :

1. Siberian tigers hang tough
2. When the going gets tough, slime molds start synthesizing
3. Tyrannosaur survivorship -- tough times for teens
4. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
5. Key molecule in plant photo-protection identified
6. Bound for destruction: Ubiquitination protects against improper Notch signaling
7. Enzyme shown to help protect genomic stability
8. Experiments provide proof of how traveling in groups protects insects
9. Experiments provide proof of how traveling in groups protects insects
10. Antibodies from plants protect against anthrax
11. Substance protects resilient staph bacteria

Post Your Comments:
(Date:11/25/2009)...ital to your health as what you eat, found researc... Their experiments in mice revealed that the daily...verthe body,s metabolic clearinghouseis mostly con...dian clock as conventional wisdom had it. , "If...umber of genes completely independent of the circa...
(Date:11/24/2009)...es from collapsing have been true life-savers. But...ed -- once the arteries are strengthened, they bec... but to leave them in place. , Prof. Meital Zilb...dical Engineering has developed a new patent-pendi... needed, then dissolves. , "Our new composite fi...
(Date:11/24/2009)...debate. A high-profile study a few years ago sugge...on from trees and leaves, evidence for a very clos...ems. , But new research from the University of W...ae provide a much richer diet for fish and other a...week in the Proceedings of the National Academy o...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 1Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 2Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 3Go to the doctor 3F Only if Im really sick 52314 1Go to the doctor 3F Only if Im really sick 52314 2Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 1Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 2Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 3
...ngs about the causes of mad cow disease show that ...also in the genes of cattle," said Juergen A. Rich...edicine and Pathobiology at Kansas State Universit...al years ago, Richt said, it was thought that the ...thy -- also called BSE or mad cow disease -- was a...
...Stevens Institute of Technology has been awarded a...e project, "MRI: Acquisition of an Inductively Cou...abrication." The Stevens team includes Yong Shi, t...gineering department; Stefan Strauf, a Professor t...e Professor in the Mechanical Engineering departme...
...t Service Southern Research Station (SRS) today an...t Disturbances: Wildfires, Storms, and Invasive Sp...ffers a synthesis of new approaches to understandi...s. , The Economics of Forest Disturbances is th...e framework for analyzing the economic effects of ...
Other Biology News:K-State professor's USDA research shows mad cow disease also caused by genetic mutation 2NSF awards two grants to Stevens for nano/micro device fabrication and nano sensor development 2Book breaks new ground in the study of economics and forest threats management 2
(Date:11/24/2009)..., , REDWOOD CITY, Calif., Nov. 24 /PRNe... GHDX ) today announced that Randy Scott, Genomic...21st Annual Piper Jaffray Health Care Conference i...:00 a.m. ET. ,, To access the live and subsequ...the Investor Relations section of Genomic Health,s...
(Date:11/24/2009)..., Program Connects Custom... Samples Collected with DNA Genotek Products , ...24, 2009 -- DNA Genotek , a leading provider of p...ation and preparation, today announced its new glo...t enhancements for DNA Genotek,s partner community...
(Date:11/24/2009)..., , SEATTLE, Nov. 24 /PRNewswire-Firs...d MTA: CTIC) management will present at the 21st A...nference will be held December 1-2, 2009, at the N...Tuesday, December 1 at 11:00 a.m. Eastern Time in ...s presentation will be available at www.cellthera...
(Date:11/23/2009)..., CHAMPAIGN, Ill. You can think of it as origami...iversity of Illinois have developed a technique fo...e silicon structures from thin films by coupling p...by capillary interactions. , The films, only a fe... is not possible with thicker pieces of the same m...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2
... 12 Anthera Pharmaceuticals, Inc., a,privately he...mmatory drugs,announced today that it has complete...urrent Acute coronary events with Near-term Cardio...designed to examine the impact of,varespladib (A-0...of an Acute,Coronary Syndrome (ACS) event. , "...
... Pharmasset, Inc. (Nasdaq: VRUS ) announced toda...have agreed with the FDA on the final design for a... of hepatitis C (HCV), slated to initiate in the f...at R7128 is advancing into a large phase 2b trial,...ief Medical Officer. "R7128 is the most advanced n...
...nuary 12 , - Reflects Strong International Gr...ding IP Management Specialist and Legal Support Se...llectual property,( http://www.cpaglobal.com ) (IP...outsourced legal support services, has today marke...ew brand worldwide. , Founded in 1969 as a spe...
Other Biology Technology:Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial 2Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial 3Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 2Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 3Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 4Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 5CPA Global Marks 40th Anniversary With Launch of New Brand 2CPA Global Marks 40th Anniversary With Launch of New Brand 3
GIBCO Fetal Bovine Serum Heat-Inactivated from Invitrogen
Mouse Anti-EGFr VIII Antibody, Unconjugated from Invitrogen
Custom siRNA, PAGE purified from Ambion
GIBCO Kanamycin Sulfate from Invitrogen
Biology Products: